259 related articles for article (PubMed ID: 7006078)
1. [The regulation of plasma aldosterone in hemodialysis patients].
Louis F; Zwahlen A; Favre H; Vallotton M
Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
[TBL] [Abstract][Full Text] [Related]
2. Control of plasma aldosterone during chronic hemodialysis.
Studer A; Záruba K; Grimm J; Kuhlmann U; Siegenthaler W; Vetter W
Clin Nephrol; 1980 Apr; 13(4):172-6. PubMed ID: 6991183
[TBL] [Abstract][Full Text] [Related]
3. [Plasma aldosterone during haemodialysis in patients with terminal renal failure].
Schnurr E; Küppers H; Wiesen K; Grabensee B
Dtsch Med Wochenschr; 1976 Jul; 101(30):1120, 1125-8. PubMed ID: 1278056
[TBL] [Abstract][Full Text] [Related]
4. The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
Krämer BK; Ress KM; Ulshöfer TM; Risler T
Nephrol Dial Transplant; 1987; 2(6):531-6. PubMed ID: 3126454
[TBL] [Abstract][Full Text] [Related]
5. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
[TBL] [Abstract][Full Text] [Related]
6. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
[TBL] [Abstract][Full Text] [Related]
7. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
[No Abstract] [Full Text] [Related]
8. Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.
Vetter W; Záruba K; Armbruster H; Beckerhoff R; Uhlschmid G; Furrer J; Siegenthaler W
Clin Nephrol; 1976 Oct; 6(4):433-6. PubMed ID: 788978
[TBL] [Abstract][Full Text] [Related]
9. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
Hory B; Henriet MT
Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
[TBL] [Abstract][Full Text] [Related]
10. Model-based analysis of potassium removal during hemodialysis.
Ciandrini A; Severi S; Cavalcanti S; Fontanazzi F; Grandi F; Buemi M; Mura C; Bajardi P; Badiali F; Santoro A
Artif Organs; 2009 Oct; 33(10):835-43. PubMed ID: 19681843
[TBL] [Abstract][Full Text] [Related]
11. Plasma 18-hydroxycorticosterone during continuous ambulatory peritoneal dialysis.
Zager PG; Frey HJ; Gerdes BG
J Lab Clin Med; 1983 Oct; 102(4):604-12. PubMed ID: 6311927
[TBL] [Abstract][Full Text] [Related]
12. Effect of bedrest on circadian rhythms of plasma renin, aldosterone, and cortisol.
Chavarri M; Ganguly A; Luetscher JA; Zager PG
Aviat Space Environ Med; 1977 Jul; 48(7):633-6. PubMed ID: 883933
[TBL] [Abstract][Full Text] [Related]
13. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
Nephron; 1977; 18(2):114-23. PubMed ID: 857174
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of plasma renin, aldosterone, catecholamines and vasopressin in chronic ambulatory peritoneal dialysis (CAPD) patients.
Zabetakis PM; Kumar DN; Gleim GW; Gardenswartz MH; Agrawal M; Robinson AG; Michelis MF
Clin Nephrol; 1987 Sep; 28(3):147-51. PubMed ID: 3311503
[TBL] [Abstract][Full Text] [Related]
15. Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.
Sasamura H; Suzuki H; Takita T; Hayashi M; Ohno J; Shirai T; Saruta T
Clin Nephrol; 1990 Jun; 33(6):288-92. PubMed ID: 2198118
[TBL] [Abstract][Full Text] [Related]
16. Plasma aldosterone in patients with end stage kidney disease.
Weidmann P; Lupu AN; Schroth P; Maxwell MH
Proc Eur Dial Transplant Assoc; 1972; 9():147-53. PubMed ID: 4668907
[No Abstract] [Full Text] [Related]
17. [Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
Novo S; Adamo L; Forte G; Galfano G; Giamporcaro A; Ferrara D; Strano A
Cardiologia; 1985 Jul; 30(7):505-10. PubMed ID: 3011264
[No Abstract] [Full Text] [Related]
18. Dopamine control of aldosterone secretion in end-stage renal failure.
García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
[TBL] [Abstract][Full Text] [Related]
19. [Blood pressure and renin in long-term hemodialysis patients].
Shin J; Sakai R; Nishioka M; Okudaira H; Arakawa T; Fujita Y; Komaba K; Nagai H
Nihon Jinzo Gakkai Shi; 1996 Jan; 38(1):13-21. PubMed ID: 8855132
[TBL] [Abstract][Full Text] [Related]
20. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
